BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2523959)

  • 1. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
    Lee HB; Blaufox MD
    J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.
    Eshima D; Taylor A; Fritzberg AR; Kasina S; Hansen L; Sorenson JF
    J Nucl Med; 1987 Jul; 28(7):1180-6. PubMed ID: 2955085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
    Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
    J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
    Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
    J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
    Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ
    Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
    Stabin M; Taylor A; Eshima D; Wooter W
    J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the clearance of technetium-99m MAG3 and iodine-131 OIH.
    Kim CK; Stritzke P; Goldsmith SJ
    J Nucl Med; 1988 Nov; 29(11):1878-9. PubMed ID: 2972816
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
    Eshima D; Taylor A
    Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of renal function with technetium-99m MAG3.
    Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
    J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the renal clearance of technetium-99m PAHIDA in dogs.
    Summerville DA; Packard AB; Bartynski B; Lim KS; Chervu LR; Treves ST
    J Nucl Med; 1987 May; 28(5):907-9. PubMed ID: 3553465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of 99mTc-mercaptoacetyltriglycine in captopril renography.
    Taylor A; Martin LG
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):731S-736S. PubMed ID: 1837994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the renal clearance of 99mTc-DTPA and inulin, 131I-hippurate and PAH and creatinine clearance in Wistar rats].
    Hagemann J; Su LM; Strangfeld D; Schürer M; Siewert H; Pietsch R; Kruse I; Priem F
    Radiobiol Radiother (Berl); 1988; 29(4):497-505. PubMed ID: 3055016
    [No Abstract]   [Full Text] [Related]  

  • 19. Glomerular filtration and tubular secretion of MAG-3 in the rat kidney.
    Müller-Suur R; Müller-Suur C
    J Nucl Med; 1989 Dec; 30(12):1986-91. PubMed ID: 2531220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.